[Differential anti-tumor effects for various regimens of endostar plus cisplatin in ovarian cancer].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Zhonghua yi xue za zhi

• Publication date

  2011-12-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.3760/CMA.J.ISSN.0376-2491.2011.47.014PMID 22333207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Normalization time window of recombinant human endostatin: an overview

  2019cites this paper
• Effects of Combined Simultaneous and Sequential Endostar and Cisplatin Treatment in a Mice Model of Gastric Cancer Peritoneal Metastases

  2017cites this paper
• Clinical observation and therapeutic evaluation of intravenous pump of recombinant human endostatin combined with TP regimen in treating patients with advanced ovarian cancer

  2015cites this paper
• Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma

  2014cites this paper
• Early efficacy of Endostar combined with chemoradiotherapy for advanced cervical cancers.

  2012cites this paper